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Abstract 
Background: Recruiting participants to a clinical study is a resource-intensive process with a high failure rate. The 
Scottish Health Research Register (SHARE) provides recruitment support service which helps researchers recruit par-
ticipants by searching patients’ Electronic Health Records (EHRs). The current study aims to evaluate the performance 
of SHARE in participant recruitment.
Methods: Recruitment projects eligible for evaluation were those that were conducted for clinical trials or observa-
tional studies and finished before 2020. For analysis of recruitment data, projects with incomplete data were excluded. 
For each project we calculated, from SHARE records, 1) the fraction of the participants recruited through SHARE as a 
percentage of the number requested by researchers (percentage fulfilled), 2) the percentage of the potential can-
didates provided by SHARE to researchers that were actually recruited (percentage provided and recruited), 3) the 
percentage of the participants recruited through SHARE of all the potentially eligible candidates identified by search-
ing registrants’ EHRs (percentage identified and recruited). Research teams of the eligible projects were invited to 
participate in an anonymised online survey. Two metrics were derived from research teams’ responses, including a) 
the fraction of the recruited over the study target number of participants (percentage fulfilled), and b) the percentage 
of the participants recruited through SHARE among the candidates received from SHARE (percentage provided and 
recruited).
Results: Forty-four projects were eligible for inclusion. Recruitment data for 24 projects were available (20 excluded 
because of missingness or incompleteness). Survey invites were sent to all the eligible research teams and received 
12 responses. Analysis of recruitment data shows the overall percentage fulfilled was 34.2% (interquartile 13.3–45.1%), 
the percentage provided and recruited 29.3% (interquartile 20.6–52.4%) and percentage identified and recruited 4.9% 
(interquartile 2.6–10.2%). Based on the data reported by researchers, percentage fulfilled was 31.7% (interquartile 
5.8–59.6%) and percentage provided and recruited was 20.2% (interquartile 8.2–31.0%).
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Background
It is a paradox that although most people are willing to 
participate in medical research, many research studies 
struggle to recruit participants [1]. Poor recruitment 
often lengthens studies, increasing the costs of research, 
and, at worst, results in underpowered inconclusive or 
abandoned studies [2]. One study in 2013 revealed that 
in the UK only 55% of studies achieved their target sam-
ple size and 45% required funding for a time-extension 
[3]. More recently, Tudur Smith et  al. conducted an 
on-line Delphi survey of 48 clinical trials units (CTUs) 
and identified ‘Research into methods to boost recruit-
ment in trials’ as the top priority in trial methodologi-
cal research [4]. Although the challenge of participant 
recruitment has been well-recognized and frequently-
stressed, strategies to deal with this problem currently 
are insufficiently evidence based. According to Treweek 
el al., only two approaches showed slight to moder-
ate recruitment improvement with high-certainty evi-
dence [5]. One of them is about adopting open rather 
than blinded placebo design and the other is to use a 
telephone reminder in addition to postal contact. Some 
researchers have turned to disease-specific registers to 
facilitate trial recruitment such as cancer register, dia-
betes register, which has obtained good results [6–9]. 
A more general approach – research register initia-
tives based on Electronic Health Records (EHRs) have 
been developed in different nations and countries with 
patient consent, e.g., ResearchMatch, [10] All of Us 
Research Program, [11] Discover-Now [12] and SHARE 
[13] and more recently without consent [14]. They pro-
vide recruitment support service by helping researchers 
identify eligible participants in the EHRs and recruit 
them into their studies.
SHARE, part of National Health Service Research Scot-
land, is an example of the EHR-based recruitment sup-
port service which seeks consent from people across 
Scotland for their EHRs to be utilized for identifying 
eligible participants for health care research [13, 15, 16]. 
The database was designed following consultation with 
patients and members of the general public [17]. Regis-
trants are predominantly approached by SHARE in hos-
pital waiting areas. As a result, the proportion of patients 
with long-term health conditions among SHARE mem-
bers is higher than the general population. And that is 
corroborated by the data from the Scottish Burden of 
Disease Study 2016 [18] and the 2016 mid-year popula-
tion estimate [19].
When a research team approaches SHARE for assis-
tance with participant recruitment, the SHARE Studies 
Access Committee establishes that the study has ethical 
approval and that the number of participants requested 
is likely to be achievable. The Health Informatics Cen-
tre (HIC) then works with the researchers to create an 
optimal search algorithm to be implemented in the 
EHR database. HIC is a National Health Service Safe 
Haven where EHRs are hosted on a local server within 
a restricted, safe IT environment. Safe havens provide a 
platform for the use of NHS electronic data in research 
feasibility, delivery and pharmacovigilance [20, 21]. Cur-
rently the data most used are demographics, hospital 
admissions (SMR01), community drug prescriptions, 
laboratory test results and cancer register. The cohort 
derived from the database search are transferred to the 
SHARE tracker system. SHARE team contact those 
potentially eligible patients by phone, email or letter, 
provide information about the study and confirm their 
interest in participation. The SHARE tracker system con-
tains contact information and a record of previous con-
tacts and responses. SHARE registrants can set a contact 
cap which sets the maximum number of studies the reg-
istrants would like to be contacted about annually when 
they register with SHARE. Following contact, if potential 
candidates express an interest in the project then, with 
permission, their details are passed on to researchers 
for further eligibility screening and enrolment. Figure 1 
shows the workflow of engaging with SHARE for partici-
pant recruitment.
Discover-Now, [12] ResearchMatch [10, 22] and ALL of 
Us [11, 23] are all similar recruitment support services. 
SHARE and Discover-Now are based in Scotland and 
England respectively while ResearchMatch and ALL of 
Us are national registers in the USA. Research Match is 
reported to have supported more than 700 studies [10, 
22]. But so far there is no study which has explored the 
performance of these EHR-based participant recruitment 
methods in a systematic way.
The large SHARE registrant base has made it attrac-
tive to researchers. However, although SHARE has 
roughly been used for recruitment to 100 health 
research studies by 2020, it is still uncertain how suc-
cessful a research infrastructure like SHARE is in terms 
Conclusions: SHARE may be a valuable resource for recruiting participants for some clinical studies. Potential 
improvements are to expand the registrant base and to incorporate more data generated during patients’ different 
health care encounters into the candidate-searching step.
Keywords: Electronic health records, Patient recruitment
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of meeting recruitment targets and improving recruit-
ment efficiency by reducing the number of people that 
researchers need to screen for different kinds of stud-
ies. Such information will help researchers decide if an 
EHR-based recruitment approach is likely to be success-
ful for their type of study. It can also inform SHARE and 
the other research support groups of the strengths and 
weaknesses of the approach.
The current paper evaluates SHARE’s performance in 
participant recruitment for clinical studies and discusses 
how SHARE can improve in the future.
Methods
Registrant composition
The statistics of registrants’ characteristics were quoted 
from SHARE’s regular reports on age, gender, disease sta-
tus and medication. Age and gender were recorded in the 
demographic dataset. Disease status was estimated based 
on the hospital admissions data and medication based on 
the community prescription data. The distribution of the 
characteristics was described with both raw numbers and 
percentages.
Recruitment performance‑data from SHARE
The SHARE team provided recruitment data for the 
included projects from their tracking records. To be 
included, studies must have completed the recruitment 
process in SHARE before 2020 and be either a clinical 
trial or an observational study. Projects were excluded 
from recruitment data analysis because SHARE could 
not provide recruitment data due to missing/incomplete 
records. Missing records were caused by projects can-
celled by researchers due to personal or study specific 
reasons. Incomplete records happened to some pro-
jects which did not progress if the researchers were not 
satisfied with the initial search result. Recruitment data 
were also incomplete for projects in which SHARE was 
only requested to send out email advertisements and was 
not further involved in recruitment. For each included 
project, the total number of participants requested by 
researchers, the number of potentially eligible partici-
pants identified through searching EHRs, the number 
of potentially eligible participants provided by SHARE 
to researchers and the number finally recruited through 
SHARE were presented. Recruitment performance 
Fig. 1 Workflow of recruiting through SHARE [13].
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was indicated by three metrics, i.e., the fraction of the 
number of the patients recruited through SHARE over 
the total number requested (percentage fulfilled), the 
percentage of the recruited among the provided (per-
centage provided and recruited), the percentage of the 
recruited among the identified (percentage identified and 
recruited).
Recruitment performance‑survey of researchers
Since SHARE is often not the only source of recruitment, 
the data only reflect the recruitment requests and out-
comes recorded by SHARE. It was considered worthwhile 
to conduct a survey of the SHARE users to investigate 
their study recruitment outcomes and their experiences 
of recruiting through SHARE. Thus, an online survey was 
conducted on Qualtrics [24] during Mar, 2020 and Apr, 
2020 of the researchers of all the eligible projects which 
finished before 2020 for trials and observational studies. 
An email with a link to the online survey was sent to each 
researcher separately along with a participant informa-
tion sheet. The researchers were asked how SHARE was 
involved in their studies, how they would rate SHARE for 
recruitment and their suggestions for improvement. They 
were also asked to report the target participant number 
of their study, the number of participants they received 
from SHARE, the number recruited through SHARE and 
through other recruitment methods as well. To ensure 
that researchers would be less likely to reject the survey 
due to worry about anonymity, all the survey questions 
were made optional, and the respondents could choose 
not to answer any question that they think might make 
them identifiable. The questionnaire and the participant 
information sheet are attached as Additional  file  1. For 
each study which we received a response, we presented 
the raw numbers the researchers reported and calculated 
the fraction of the number recruited through SHARE 
over the total recruitment target (percentage fulfilled) 
and the percentage of the number recruited among the 
number received from SHARE (percentage provided and 
recruited).
Analysis
Centre and variation of recruitment performance across 
studies were shown by median and interquartile range. 
All the calculations were done in the statistical software 
R(3.6.1) [25].
Results
As of August 2020, there were 283,791 patients regis-
tering with SHARE. The distributions of their age, gen-
der, disease status and medication type are shown in 
the Table  1. Overall, 6.4% of the population over 16 in 
Scotland registered with SHARE. Figure  2 indicates the 
Table 1 Distribution of characteristics of the SHARE registrants




 11–15 865 0.3
 16–19 1654 0.6
 20–29 20,130 7.1
 30–39 30,492 10.7
 40–49 34,678 12.2
 50–59 52,509 18.5
 60–69 58,775 20.7
 70–79 55,791 19.7
 80–89 25,457 9.0
 90+ 3440 1.2
Sex
 Female 170,459 60.1
 Male 113,332 39.9
Disease status
 Any malignancy 20,124 7.1
 Cerebrovascular disease 8734 3.1
 Chronic pulmonary disease 22,454 7.9
 Congestive heart failure 5329 1.9
 Dementia 881 0.3
 Diabetes with chronic complication 1571 0.6
 Diabetes without chronic complication 18,476 6.5
 Hemiplegia or paraplegia 1481 0.5
 Metastatic solid tumour 4329 1.5
 Mild liver disease 4575 1.6
 Moderate or severe liver disease 1255 0.4
 Myocardial infarction 9252 3.3
 Peptic ulcer disease 4152 1.5
 Peripheral vascular disease 5495 1.9
 Renal disease 7449 2.6
 Rheumatic disease 4862 1.7
Medication type 0.0
 Analgesics 86,839 30.6
 Antidiabetic Drugs 27,042 9.5
 Antidepressant 72,201 25.4
 Antihypertensives 89,418 31.5
 Cardiovascular System 144,363 50.9
 Central Nervous System 130,106 45.8
 Endocrine System 80,870 28.5
 Gastro-Intestinal System 170,990 60.3
 Infections 92,156 32.5
 Inhaled Steroids 29,588 10.4
 Lipid Modifying Drugs 67,433 23.8
 Muscoskeletal And Joint Disease 67,483 23.8
 NSAIDs including Cox-2 35,408 12.5
 Respiratory System 65,127 22.9
 Skin 71,544 25.2
 Topical Steroids 43,186 15.2
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percentages of SHARE registrants in the 16+ population 
in each health board across Scotland.
Figure  3 is the flow diagram of including and exclud-
ing projects for recruitment data analysis. Forty-four 
projects for trials or observational studies finished 
before 2020. They were eligible for inclusion, but 17 were 
excluded from recruitment data analysis due to missing 
records because the projects were cancelled by research-
ers due to personal or study specific reasons. Two pro-
jects were excluded because they did not progress after 
Fig. 2 The proportion of SHARE registrants in the 16+ population in each health board across Scotland
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the initial search for eligible patients in the EHRs. One 
project was excluded because SHARE was not involved 
in direct recruitment of patients, so recruitment data was 
incomplete. Finally, 24 projects were included for recruit-
ment data analysis.
Table  2 shows the comparison of some character-
istics between included and excluded projects. Over-
all, excluded projects are not too different from those 
included in terms of time, study type, recruiting region 
and research domain.
Fig. 3 Diagram of including and excluding projects for recruitment data analysis
Table 2 Comparison of characteristics between included and excluded SHARE projects
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The 24 projects included recruited study subjects in 
various regions across Scotland. The majority (11 pro-
jects) recruited participants in the East and 2 recruited 
all over Scotland. Tables 3 and 4 provide details for each 
project and by study type respectively in terms of the 
region covered, the study inclusion and exclusion crite-
ria, the number of participants requested, the number 
of potentially eligible individuals found through search-
ing registrants’ EHRs, the number of people provided to 
researchers, the number recruited into the study and the 
three metrics of recruitment performance calculated. 
The overall trend is also presented with median and 
interquartile for trial and observational study separately.
Overall, 34.2% (interquartile range 13.3–45.1%) of the 
number of participants requested by researchers were 
fulfilled through SHARE. Further analysis of the cohort 
provided to researchers showed that the average recruit-
ment rate was 29.3% (interquartile 20.6–52.4%). The 
number of potential candidates identified by searching 
EHRs ranged from 94 to 509 across studies and on aver-
age there were 237 people to be further screened for eli-
gibility for a study.
We received 12/44 responses to the online survey 
(response rate 27%). Two researchers chose not to reveal 
their study names. There were three studies of which 
the names reported could not be matched with those 
recorded at SHARE. Among the remaining seven identi-
fiable studies, four are trials and three are observational 
studies.
According to the survey results, two studies used 
SHARE as the principal means of participant recruit-
ment. Six reported that they adopted SHARE as a sup-
plementary recruitment method in addition to a variety 
of approaches such as other patient registers, direct clini-
cal contact, mass media, social media. The other four 
studies turned to SHARE after their original recruit-
ment strategy failed. SHARE was involved within the first 
three months of participant recruitment for five studies 
and during months 3–6 for another two studies. In the 
other five studies, SHARE was used in the late phase of 
the recruitment including two engaging SHARE after one 
year into the study.
The participant target and recruitment outcomes of 
different methods reported by researchers and the study 
information for identifiable studies are presented in the 
Table 5. The recruitment performance calculated accord-
ing to outcomes reported by researchers are also pre-
sented in it. The overall fraction of the number recruited 
through SHARE over the study target number was 31.7% 
(interquartile 5.8–59.6%). The recruitment rate centred 
at 20.2% (interquartile 8.2–31.0%) in terms of the num-
ber of candidates received. Notably, the researcher of 
study Ω responded “impossible via other means” when 
asked about the difficulty encountered during participant 
recruitment while SHARE managed to find all the par-
ticipants for it.
Seven researchers (58.3%) agreed that the participants 
transferred to them by SHARE were either more eligible 
or about the same as those found through other methods. 
Eight respondents (66.7%) considered SHARE a quicker 
way to recruit participants compared with other means 
of recruitment. Whereas 58% of those surveyed gave less 
favourable responses citing the cost of recruiting through 
SHARE.
When asked for suggestions for improvement, the most 
frequently raised issue (mentioned by 3 respondents) can 
be summarized as the need to improve the eligibility of 
the candidates transferred. Researchers hoped to receive 
as few ineligible candidates as possible so that they would 
be able to save some resources on filtering out ineligible 
participants. Other than that, one of the researchers was 
very discontent with the cost charged by SHARE. One 
researcher requested more rapid responses from the 
SHARE team. Another researcher mentioned improving 
the ability to identify mild cognitive impairment. One 
respondent encouraged SHARE to continue enlarging 
the registrant base.
The raw data obtained from the survey are attached as 
Additional file 2.
Discussion
Based on the recruitment data at SHARE, the register 
can provide over one third of the number of participants 
requested by study teams on average. Generally, one eli-
gible participant is recruited for every 3 to 4 candidates 
provided to researchers by SHARE. The recruitment 
performance derived from the survey is a little poorer 
compared to that from the SHARE data (31.7 and 20.2% 
regarding target fulfilment and effective recruitment of 
candidates provided respectively) and with more vari-
ation. The percentage fulfilment reported by research-
ers may seem lower since it was calculated against the 
total target number of a study rather than the number 
SHARE was requested for. It reflected how much SHARE 
contributed to the recruitment outcome of a study, but 
it might be an underestimate because researchers might 
have already recruited most of the participants needed 
through other methods then they wouldn’t request that 
many from SHARE. Overall, most researchers consider 
SHARE a quicker way to recruit participants and the can-
didates provided by SHARE same likely to be eligible for 
recruitment as other methods if not more.
SHARE has shown relatively good performance com-
pared with other recruitment methods for most stud-
ies reported in the survey. Researchers need to screen 
5 candidates from SHARE for one successful recruit 
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on average and 75% screen fewer than 12. This recruit-
ment performance is still encouraging compared to 
those reported by other studies. For example, a cardio-
vascular disease trial reported to screen 5 candidates 
per participant recruited with the method of offering 
£100 upon successful recruitment at first place [26]. 
The number of candidates screened in some other 
studies ranged between 8 and 26 adopting one or more 
recruitment strategies such as small financial incen-
tive, church involvement, telephone reminder, text 
message [27–30].
There are several studies for which SHARE seems 
to have poorer performance than other recruitment 
methods, i.e., study V, study B, study I, study Φ. But 
these studies were reported to involve SHARE in 
their recruitment at a late stage, and all but study V 
claimed that other recruitment strategies were fail-
ing, which to some extent indicates the extreme dif-
ficulty of recruitment for these studies. Considering 
SHARE was approached later in the recruitment phase 
of these studies, it is understandable that SHARE con-
tributed fewer participants than other methods. On 
the contrary, according to the data held by SHARE, 
the recruitment performance regarding the number 
of participants requested for study V was about 87%, 
which is quite good. However, studies which had highly 
restrictive inclusion and exclusion criteria posed a 
challenge when those criteria cannot be mapped to 
structured EHR data. SHARE mainly use hospital 
admissions data to identify disease status but some 
conditions are either not coded in the EHRs or incom-
pletely coded such as menstrual bleeding required by 
study B and mild cognitive impairment required by 
study Φ. The relatively poor performance in study I 
is probably due to the reason that most hypertensive 
patients captured in secondary care data suffer from 
comorbidity which made them ineligible according to 
the exclusion criteria of the study and mild hyperten-
sive patients are mostly seen by their general practi-
tioners (GPs). Therefore, SHARE is unable to identify 
these patients from secondary care data and find as 
many eligible patients for researchers as they wanted 
for their study.
To solve these problems, it is important that SHARE 
access EHRs generated from as many patients’ health 
care encounters as possible including diagnosis dur-
ing primary care, in-hospital medication records, 
discharge notes, etc. This modification would also 
contribute a solution to researchers’ request for more 
quality control on the eligibility of the candidates pro-
vided. Now, whether the cohort built from EHRs meet 
researchers’ criteria depends hugely on what kind of 
condition is under consideration, whether it is coded 
in hospital admissions data and how accurately it 
is recorded. Data currently in use are mainly coded 
according to International Classification of Diseases 
(ICD). ICD codes are widely criticized for lack of gran-
ularity or aetiological information and poor accuracy 
for identification of certain diseases [31]. There are 
a few studies which have proved that the accuracy of 
pre-screening can be significantly increased and work-
load can be reduced by using both clinical narrative 
data and coded data to search for potentially eligible 
candidates [31–34]. Incorporating more data sources 
is likely to overcome many of those issues and help 
SHARE improve. According to the SHARE team, pri-
mary care data is now in the process of being added to 
the data inventory.
The limitations of this study include the fact that 
the major source of the recruitment data was the 
SHARE management team and not all studies were 
analysed for recruitment performance so there 
might exist selection bias of providing data for stud-
ies with relatively good results. We additionally 
conducted a survey involving the research teams of 
all the eligible projects. Recruitment data collected 
from the survey complemented the evaluation of 
recruitment performance based on SHARE records. 
Another limitation of the study is the seemingly 
low survey response rate, though a response rate of 
20–30% is considered acceptable for an online sur-
vey according to SurveyMonkey [35]. The survey 
was meant to let researchers vent their real thoughts 
without worry of being identified and their future 
studies being affected because of them giving nega-
tive feedback. Although the response rate was not 
too high, it was designed and conducted in a strin-
gent way. We believe that we have successfully gath-
ered miscellaneous researchers’ views on the effect 
of the service on their studies’ recruitment perfor-
mance and have drawn valuable information from 
them. Other survey methods may have resulted in 
even lower response rates.
Conclusions
In conclusion, SHARE may be a valuable resource for 
recruiting participants for some clinical studies. Cur-
rently it has blind spots in identifying some symptoms 
and minor ailments due to the intrinsic lack of access 
to the data reflecting those healthcare encounters. 
With the continuing growing number of registrants 
and the potential of eased restriction of data access, 
SHARE can become an even more powerful tool for 
efficient and effective participant recruitment to health 
research.
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